ABD-Y

N/A

Report date: 2025/01/26 16:01:07
NME

Base Information

Drug NameABD-Y
Drug Alias Nameserine hydrolase inhibitors for cancer (H Lundbeck)serine hydrolase inhibitors for cancer (Abide Therapeutics)ABD-Y
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHydrolases inhibitors
TargetsHydrolases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbide Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesH. Lundbeck A/S
Inactive CompaniesAbide Therapeutics Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A